Athersys Inc. is a biopharmaceutical company that is focused in the field of regenerative medicine. It is engaged in the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life.


Updates from The Motley Fool

Latest updates on Athersys from Fool.com.


Stock Performance

ATHX vs. S&P 500 | 2 Year Performance
View Interactive ATHX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Athersys.
Current Price: $1.96
Prev Close: $2.02
Open: $2.00
Bid: $1.90
Ask: $2.18
Day's Range: $1.96 - $2.02
52wk Range: $0.94 - $2.90
Volume: 174,707
Avg Vol 277,679
Market Cap: $163.24M
P/E (ttm): -33.67
EPS (ttm): -$0.06
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Athersys.
CAPS Rating 1 out of 5
 
78 Outperform
19 Underperform
CAPS All Stars
 
7 Outperform
12 Underperform

How do you think Athersys will perform against the market?



You pick for Athersys is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Gil Van Bokkelen, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Athersys.

Athersys Inc. is a biopharmaceutical company that is focused in the field of regenerative medicine. It is engaged in the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers